세계의 의료용 외골격 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2033년)

Global Medical Exoskeleton Market size is anticipated to grow from USD 0.47 Billion in 2024 to USD 14.31 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 45.88% during the forecast period of 2026 to 2033.

The medical exoskeleton market is poised for significant growth as advancements in robotics and artificial intelligence converge to enhance rehabilitation and mobility solutions. These wearable robotic devices are designed to assist individuals with mobility impairments, offering a promising avenue for improving the quality of life for patients recovering from strokes, spinal cord injuries, or other debilitating conditions. As the global population ages and the prevalence of chronic diseases rises, the demand for innovative rehabilitation technologies is expected to surge. The integration of smart sensors and machine learning algorithms into exoskeletons will further refine their functionality, enabling personalized therapy regimens that adapt to the user's specific needs and progress.

Moreover, the expansion of healthcare infrastructure in emerging markets presents a lucrative opportunity for the medical exoskeleton sector. As hospitals and rehabilitation centers increasingly adopt advanced technologies to enhance patient outcomes, the integration of exoskeletons into standard care protocols will become more prevalent. Collaborations between technology firms and healthcare providers are likely to accelerate the development of cost-effective solutions, making these devices more accessible to a broader demographic. Additionally, ongoing research into lightweight materials and energy-efficient designs will enhance the usability and comfort of exoskeletons, driving their adoption in both clinical and home settings.

The future landscape of the medical exoskeleton market will also be shaped by regulatory advancements and reimbursement policies. As more clinical studies validate the efficacy of exoskeletons in rehabilitation, regulatory bodies are expected to streamline approval processes, facilitating faster market entry for innovative products. Furthermore, the establishment of reimbursement frameworks will incentivize healthcare providers to incorporate these technologies into their treatment offerings. As the market evolves, the focus will shift towards creating multifunctional exoskeletons that not only assist with mobility but also provide therapeutic benefits, thereby revolutionizing rehabilitation practices and enhancing patient care.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Component

• Hardware
• Software

By Type

• Powered Exoskeleton
• Passive Exoskeleton

By Mobility

• Stationary
• Mobile

By Extremity

• Lower Extremity
• Upper Extremity
• Full Body
• COMPANIES PROFILED
• Parker Hannifin Corp
• Honda Motor Co. Ltd.
• Bioventus
• Hocoma
• Wearable Robotics srl
• Cyberdyne Inc.
• Ekso Bionics
• ReWalk Robotics
• B-Temia
• Bionik
• Rex Bionics Ltd.
• ExoAtlet
• SuitX
• Myomo Inc.
• Wandercraft
• The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. MEDICAL EXOSKELETON INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porters Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Component
  • 3.7.2 Market Attractiveness Analysis By Type
  • 3.7.3 Market Attractiveness Analysis By Mobility
  • 3.7.4 Market Attractiveness Analysis By Extremity
  • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL MEDICAL EXOSKELETON MARKET ANALYSIS BY COMPONENT

• 5.1. Overview By Component
• 5.2. Historical and Forecast Data Analysis By Component
• 5.3. Hardware Historic and Forecast Sales By Regions
• 5.4. Software Historic and Forecast Sales By Regions

6. GLOBAL MEDICAL EXOSKELETON MARKET ANALYSIS BY TYPE

• 6.1. Overview By Type
• 6.2. Historical and Forecast Data Analysis By Type
• 6.3. Powered Exoskeleton Historic and Forecast Sales By Regions
• 6.4. Passive Exoskeleton Historic and Forecast Sales By Regions

7. GLOBAL MEDICAL EXOSKELETON MARKET ANALYSIS BY MOBILITY

• 7.1. Overview By Mobility
• 7.2. Historical and Forecast Data Analysis By Mobility
• 7.3. Stationary Historic and Forecast Sales By Regions
• 7.4. Mobile Historic and Forecast Sales By Regions

8. GLOBAL MEDICAL EXOSKELETON MARKET ANALYSIS BY EXTREMITY

• 8.1. Overview By Extremity
• 8.2. Historical and Forecast Data Analysis By Extremity
• 8.3. Lower Extremity Historic and Forecast Sales By Regions
• 8.4. Upper Extremity Historic and Forecast Sales By Regions
• 8.5. Full Body Historic and Forecast Sales By Regions

9. GLOBAL MEDICAL EXOSKELETON MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2 North America By Segment Sales Analysis
  • 9.3.3 North America By Country Sales Analysis
  • 9.3.4 United States Sales Analysis
  • 9.3.5 Canada Sales Analysis
  • 9.3.6 Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2 Europe By Segment Sales Analysis
  • 9.4.3 Europe By Country Sales Analysis
  • 9.4.4 United Kingdom Sales Analysis
  • 9.4.5 France Sales Analysis
  • 9.4.6 Germany Sales Analysis
  • 9.4.7 Italy Sales Analysis
  • 9.4.8 Russia Sales Analysis
  • 9.4.9 Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2 Asia Pacific By Segment Sales Analysis
  • 9.5.3 Asia Pacific By Country Sales Analysis
  • 9.5.4 China Sales Analysis
  • 9.5.5 India Sales Analysis
  • 9.5.6 Japan Sales Analysis
  • 9.5.7 South Korea Sales Analysis
  • 9.5.8 Australia Sales Analysis
  • 9.5.9 South East Asia Sales Analysis
  • 9.5.10 Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2 Latin America By Segment Sales Analysis
  • 9.6.3 Latin America By Country Sales Analysis
  • 9.6.4 Brazil Sales Analysis
  • 9.6.5 Argentina Sales Analysis
  • 9.6.6 Peru Sales Analysis
  • 9.6.7 Chile Sales Analysis
  • 9.6.8 Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2 Middle East & Africa By Segment Sales Analysis
  • 9.7.3 Middle East & Africa By Country Sales Analysis
  • 9.7.4 Saudi Arabia Sales Analysis
  • 9.7.5 UAE Sales Analysis
  • 9.7.6 Israel Sales Analysis
  • 9.7.7 South Africa Sales Analysis
  • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE MEDICAL EXOSKELETON COMPANIES

• 10.1. Medical Exoskeleton Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11. COMPANY PROFILES OF MEDICAL EXOSKELETON INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Parker Hannifin Corp
  • 11.3.1 Company Overview
  • 11.3.2 Company Revenue
  • 11.3.3 Products
  • 11.3.4 Recent Developments
• 11.4. Honda Motor Co. Ltd.
  • 11.4.1 Company Overview
  • 11.4.2 Company Revenue
  • 11.4.3 Products
  • 11.4.4 Recent Developments
• 11.5. Bioventus
  • 11.5.1 Company Overview
  • 11.5.2 Company Revenue
  • 11.5.3 Products
  • 11.5.4 Recent Developments
• 11.6. Hocoma
  • 11.6.1 Company Overview
  • 11.6.2 Company Revenue
  • 11.6.3 Products
  • 11.6.4 Recent Developments
• 11.7. Wearable Robotics Srl
  • 11.7.1 Company Overview
  • 11.7.2 Company Revenue
  • 11.7.3 Products
  • 11.7.4 Recent Developments
• 11.8. Cyberdyne Inc.
  • 11.8.1 Company Overview
  • 11.8.2 Company Revenue
  • 11.8.3 Products
  • 11.8.4 Recent Developments
• 11.9. Ekso Bionics
  • 11.9.1 Company Overview
  • 11.9.2 Company Revenue
  • 11.9.3 Products
  • 11.9.4 Recent Developments
• 11.10. ReWalk Robotics
  • 11.10.1 Company Overview
  • 11.10.2 Company Revenue
  • 11.10.3 Products
  • 11.10.4 Recent Developments
• 11.11. B-Temia
  • 11.11.1 Company Overview
  • 11.11.2 Company Revenue
  • 11.11.3 Products
  • 11.11.4 Recent Developments
• 11.12. Bionik
  • 11.12.1 Company Overview
  • 11.12.2 Company Revenue
  • 11.12.3 Products
  • 11.12.4 Recent Developments
• 11.13. Rex Bionics Ltd.
  • 11.13.1 Company Overview
  • 11.13.2 Company Revenue
  • 11.13.3 Products
  • 11.13.4 Recent Developments
• 11.14. ExoAtlet
  • 11.14.1 Company Overview
  • 11.14.2 Company Revenue
  • 11.14.3 Products
  • 11.14.4 Recent Developments
• 11.15. SuitX
  • 11.15.1 Company Overview
  • 11.15.2 Company Revenue
  • 11.15.3 Products
  • 11.15.4 Recent Developments
• 11.16. Myomo Inc.
  • 11.16.1 Company Overview
  • 11.16.2 Company Revenue
  • 11.16.3 Products
  • 11.16.4 Recent Developments
• 11.17. Wandercraft
  • 11.17.1 Company Overview
  • 11.17.2 Company Revenue
  • 11.17.3 Products
  • 11.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies